Ocugen-BBIL, COVID-19 Vaccine (Covaxin), Co-development, Supply & Commercialization Agreement Post author:GHIAA Admin Post published:December 26, 2021 Post category: Continue ReadingOcugen-BBIL, COVID-19 Vaccine (Covaxin), Co-development, Supply & Commercialization Agreement
CureVac – GSK, COVID-19 Vaccine Collaboration and License Agreement Post author:GHIAA Admin Post published:December 15, 2021 Post category: Continue ReadingCureVac – GSK, COVID-19 Vaccine Collaboration and License Agreement
Merck – MPP, Molnupiravir License Agreement Post author:GHIAA Admin Post published:November 22, 2021 Post category: Continue ReadingMerck – MPP, Molnupiravir License Agreement
Moderna – Lonza, COVID-19 mRNA Vaccine & Therapies, Manufacturing & Process Development Agreement Post author:GHIAA Admin Post published:November 18, 2021 Post category: Continue ReadingModerna – Lonza, COVID-19 mRNA Vaccine & Therapies, Manufacturing & Process Development Agreement
Fiocruz – AstraZeneca, COVID-19 Vaccine Technology Transfer Agreement Post author:GHIAA Admin Post published:November 5, 2021 Post category: Continue ReadingFiocruz – AstraZeneca, COVID-19 Vaccine Technology Transfer Agreement
Novavax – Serum Institute of India, COVID-19 Vaccine Supply and License Agreement Post author:GHIAA Admin Post published:September 10, 2021 Post category: Continue ReadingNovavax – Serum Institute of India, COVID-19 Vaccine Supply and License Agreement
US Department of Defense – Janssen, COVID-19 Vaccine Large Scale Manufacturing Agreement Post author:GHIAA Admin Post published:September 9, 2021 Post category: Continue ReadingUS Department of Defense – Janssen, COVID-19 Vaccine Large Scale Manufacturing Agreement
CEPI – Valneva, Chikungunya Vaccine Funding Agreement Post author:GHIAA Admin Post published:August 25, 2021 Post category: Continue ReadingCEPI – Valneva, Chikungunya Vaccine Funding Agreement
Fiocruz – AstraZeneca, COVID-19 Technological Order Agreement Post author:GHIAA Editor Post published:July 1, 2021 Post category: Continue ReadingFiocruz – AstraZeneca, COVID-19 Technological Order Agreement